D.S. Kerr

736 total citations
20 papers, 576 citations indexed

About

D.S. Kerr is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Clinical Biochemistry. According to data from OpenAlex, D.S. Kerr has authored 20 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 4 papers in Clinical Biochemistry. Recurrent topics in D.S. Kerr's work include Neuroscience and Neuropharmacology Research (11 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Metabolism and Genetic Disorders (4 papers). D.S. Kerr is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Metabolism and Genetic Disorders (4 papers). D.S. Kerr collaborates with scholars based in New Zealand, United States and United Kingdom. D.S. Kerr's co-authors include Olivier Thibault, Lee W. Campbell, P. W. Landfield, Wickliffe C. Abraham, David Cavan, Douglas O. Mountfort, James Kevin Chipman, Nuala A. Helsby, Andreas J. Gescher and Patrick T. Holland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Clinical Nutrition and Neurology.

In The Last Decade

D.S. Kerr

20 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.S. Kerr New Zealand 12 196 171 151 121 77 20 576
Naoko Yamaguchi Japan 15 98 0.5× 137 0.8× 201 1.3× 79 0.7× 19 0.2× 50 649
Guoming Zhang China 9 199 1.0× 175 1.0× 40 0.3× 43 0.4× 48 0.6× 31 548
Anthony C Kuhlmann United States 8 303 1.5× 140 0.8× 27 0.2× 14 0.1× 69 0.9× 8 655
P Joanny France 13 164 0.8× 168 1.0× 55 0.4× 47 0.4× 23 0.3× 43 553
Helena Havlı́ková Czechia 13 122 0.6× 87 0.5× 134 0.9× 135 1.1× 15 0.2× 18 487
Qing‐Hui Chen United States 18 104 0.5× 240 1.4× 34 0.2× 65 0.5× 67 0.9× 54 857
Cristiane Batassini Brazil 13 112 0.6× 126 0.7× 17 0.1× 28 0.2× 58 0.8× 17 477
Pandichelvam Veeraiah Netherlands 10 96 0.5× 101 0.6× 62 0.4× 90 0.7× 16 0.2× 21 453
J. Julesz Hungary 16 267 1.4× 229 1.3× 245 1.6× 107 0.9× 45 0.6× 56 792
John C. Butte United States 12 58 0.3× 159 0.9× 121 0.8× 76 0.6× 15 0.2× 22 471

Countries citing papers authored by D.S. Kerr

Since Specialization
Citations

This map shows the geographic impact of D.S. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.S. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.S. Kerr more than expected).

Fields of papers citing papers by D.S. Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.S. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.S. Kerr. The network helps show where D.S. Kerr may publish in the future.

Co-authorship network of co-authors of D.S. Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of D.S. Kerr. A scholar is included among the top collaborators of D.S. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.S. Kerr. D.S. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Read, Morgayn I., Joanne C. Harrison, D.S. Kerr, & Ivan A. Sammut. (2015). Atenolol offers better protection than clonidine against cardiac injury in kainic acid‐induced status epilepticus. British Journal of Pharmacology. 172(19). 4626–4638. 10 indexed citations
4.
Tyndall, Joel D. A., et al.. (2010). In vivo seizure induction and affinity studies of domoic acid and isodomoic acids-D, -E and -F. Neuropharmacology. 59(3). 129–138. 13 indexed citations
5.
6.
Holland, Patrick T., et al.. (2008). In vivo seizure induction and pharmacological preconditioning by domoic acid and isodomoic acids A, B and C. Neuropharmacology. 55(8). 1412–1418. 18 indexed citations
7.
Vespasiani, Giacomo, Maria Chiara Rossi, Antonio Nicolucci, et al.. (2008). Comparison between the "Diabetes Interactive Diary" system and standard carbohydrate counting education : an open label, multicentre, randomised study. 1 indexed citations
8.
Holland, Patrick T., Andrew I. Selwood, Kristen L. King, et al.. (2007). Isodomoic acids A and C exhibit low KA receptor affinity and reduced in vitro potency relative to domoic acid in region CA1 of rat hippocampus. Toxicon. 50(5). 627–638. 13 indexed citations
9.
Neilson, Derek, Robert M. Eiben, Marie E. Varnes, et al.. (2003). Autosomal dominant acute necrotizing encephalopathy. Neurology. 61(2). 226–230. 54 indexed citations
10.
Tasker, R. Andrew, Paul B. Bernard, Tracy A. Doucette, et al.. (2002). Comparison of the in vitro and in vivo neurotoxicity of three new sources of kainic acid. Amino Acids. 23(1-3). 45–54. 7 indexed citations
11.
Cavan, David, et al.. (2002). Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers. Diabetes Technology & Therapeutics. 4(5). 607–613. 56 indexed citations
12.
Kerr, D.S., et al.. (1999). A neurophysiological method of rapid detection and analysis of marine algal toxins. Toxicon. 37(12). 1803–1825. 23 indexed citations
13.
Helsby, Nuala A., James Kevin Chipman, Andreas J. Gescher, & D.S. Kerr. (1998). Inhibition of Mouse and Human CYP 1A- and 2E1-dependent Substrate Metabolism by the Isoflavonoids Genistein and Equol. Food and Chemical Toxicology. 36(5). 375–382. 39 indexed citations
15.
Kerr, D.S. & Wickliffe C. Abraham. (1996). LTD: Many means to how many ends?. Hippocampus. 6(1). 30–34. 4 indexed citations
16.
Kerr, D.S. & Wickliffe C. Abraham. (1995). Cooperative interactions among afferents govern the induction of homosynaptic long-term depression in the hippocampus.. Proceedings of the National Academy of Sciences. 92(25). 11637–11641. 55 indexed citations
17.
Kerr, D.S., Lee W. Campbell, Olivier Thibault, & P. W. Landfield. (1992). Hippocampal glucocorticoid receptor activation enhances voltage-dependent Ca2+ conductances: relevance to brain aging.. Proceedings of the National Academy of Sciences. 89(18). 8527–8531. 208 indexed citations
18.
Rutledge, S. Lane, et al.. (1989). Pyruvate carboxylase deficiency: Acute exacerbation after ACTH treatment of infantile spasms. Pediatric Neurology. 5(4). 249–252. 16 indexed citations
19.
Ruch, T. C. & D.S. Kerr. (1982). Decreased essential amino acid requirements without catabolism in phenylketonuria and maple syrup urine disease. American Journal of Clinical Nutrition. 35(2). 217–228. 11 indexed citations
20.
Kerr, D.S. & D Picou. (1981). Fasting glucose production in the smaller of twins with epinephrine-deficient hypoglycemia. Metabolism. 30(1). 18–26. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026